Company news
Milestone Pharmaceuticals Inc. news in 2021
Milestone Pharmaceuticals Inc.'s news releases, calls and decks from 2021, newest first.
Milestone Pharmaceuticals Announces Presentation of Heart Rate Analysis of NODE-301 Trial of Etripamil in Patients with PSVT
November 14, 2021
Milestone Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Clinical and Corporate Update
November 11, 2021
Milestone Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Clinical and Corporate Update
August 10, 2021
Milestone Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Clinical, Regulatory, and Corporate Update
May 16, 2021
Milestone Pharmaceuticals Announces Late-Breaker Oral Presentation of NODE-301 Data at ACC.21
May 16, 2021
Milestone Pharmaceuticals Announces Exclusive License Agreement with Ji Xing Pharmaceuticals to Develop and Commercialize Etripamil for PSVT in Greater China
May 16, 2021
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Clinical and Corporate Update
March 28, 2021
Milestone Pharmaceuticals Announces First Patient Enrolled in the ReVeRA Study, its Phase 2 Trial of Etripamil in Atrial Fibrillation and Rapid Ventricular Rate
March 28, 2021
Decks in 2021
- Investor Presentation (November 2021)
Investor deck · 39 slides · Nov 12, 2021
- Investor Presentation (June 2021)
Investor deck · 34 slides · Jun 2, 2021